Subscribe Us

header ads

Recents

header ads

Lab on Chip Market Size, Growth, Demands Outlook and Forecasts to 2030

Precedence Research - February 02, 2023

According to the research report, the global lab on chip market size is expected to touch USD 15 Billion by 2030, from USD 6.4 Billion in 2022, growing with a significant CAGR of 11.24% from 2022 to 2030. 

Lab on Chip Market Size 2021 to 2030

The lab on chip report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global lab on chip in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global lab on chip market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global lab on chip during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1716

 Report Scope of the Lab on Chip Market

Report CoverageDetails
Market Size by 2030USD 15 Billion
Growth Rate from 2022 to 2030

CAGR of 11.24%

Largest MarketNorth America
Fastest MarketAsia Pacific
Base Year2021
Forecast Period2022 to 2030
Segments CoveredProduct, Technology, Application, End-Use, Geography

This study covers a detailed segmentation of the global lab on chip market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global lab on chip market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

 

  • Micronit
  • MIMETAS
  • BEOnChip
  • Nortis Bio
  • TisssUse
  • InSphero
  • Elvesys
  • Mesobiotech
  • AxoSim
  • Emulate Bio
  • Tara Biosystems
  • Hepregen
  • Hurel Corporation
  • Cherry Biotech
  • Alveolix
  • BiomimiX
  • BioIVT
  • 4D Cell
  • Fluigent

Market Segmentation

 By Product

  • Reagents & Consumables
  • Software
  • IV Needles

By Technology

  • Microarrays
  • Microfluidics
  • Tissue Biochip
  • Others

By Application

By End-Use

  • Hospitals and Clinics
  • Biotechnology and Pharmaceuticals Companies
  •  Forensic Laboratories
  • Diagnostics Centers
  • Academic and Research Institutes

 By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Research Methodology

The research methodology adopted by analysts for compiling the global lab on chip report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global lab on chip market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Lab on Chip Market 

5.1. COVID-19 Landscape: Lab on Chip Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Lab on Chip Market, By Product

8.1. Lab on Chip Market, by Table, 2022-2030

8.1.1. Reagents & Consumables

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Software

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. IV Needles

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Lab on Chip Market, By Technology

9.1. Ambulatory Surgical Center Market, by End User e, 2022-2030

9.1.1. Microarrays

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Microfluidics

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Tissue Biochip

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Lab on Chip Market, By Application 

10.1. Lab on Chip Market, by Application, 2022-2030

10.1.1. Genomics

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Proteomics

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Point of Care Diagnostics

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Drug Discovery

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Lab on Chip Market, By End-Use 

11.1. Lab on Chip Market, by Equipment, 2022-2030

11.1.1. Hospitals and Clinics

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Biotechnology and Pharmaceuticals Companies

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Forensic Laboratories

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Diagnostics Centers

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Academic and Research Institutes

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Lab on Chip Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Table (2017-2030)

12.1.2. Market Revenue and Forecast, by End User (2017-2030)

12.1.3. Market Revenue and Forecast, by Application (2017-2030)

12.1.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Table (2017-2030)

12.1.5.2. Market Revenue and Forecast, by End User (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.1.5.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Table (2017-2030)

12.1.6.2. Market Revenue and Forecast, by End User (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.1.6.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Table (2017-2030)

12.2.2. Market Revenue and Forecast, by End User (2017-2030)

12.2.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Table (2017-2030)

12.2.5.2. Market Revenue and Forecast, by End User (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.5.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Table (2017-2030)

12.2.6.2. Market Revenue and Forecast, by End User (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.6.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Table (2017-2030)

12.2.7.2. Market Revenue and Forecast, by End User (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.7.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Table (2017-2030)

12.2.8.2. Market Revenue and Forecast, by End User (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.8.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Table (2017-2030)

12.3.2. Market Revenue and Forecast, by End User (2017-2030)

12.3.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Table (2017-2030)

12.3.5.2. Market Revenue and Forecast, by End User (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.5.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Table (2017-2030)

12.3.6.2. Market Revenue and Forecast, by End User (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.6.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Table (2017-2030)

12.3.7.2. Market Revenue and Forecast, by End User (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.7.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Table (2017-2030)

12.3.8.2. Market Revenue and Forecast, by End User (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.8.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Table (2017-2030)

12.4.2. Market Revenue and Forecast, by End User (2017-2030)

12.4.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Table (2017-2030)

12.4.5.2. Market Revenue and Forecast, by End User (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.5.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Table (2017-2030)

12.4.6.2. Market Revenue and Forecast, by End User (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.6.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Table (2017-2030)

12.4.7.2. Market Revenue and Forecast, by End User (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.7.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Table (2017-2030)

12.4.8.2. Market Revenue and Forecast, by End User (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.8.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Table (2017-2030)

12.5.2. Market Revenue and Forecast, by End User (2017-2030)

12.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.5.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Table (2017-2030)

12.5.5.2. Market Revenue and Forecast, by End User (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.5.5.4. Market Revenue and Forecast, by Equipment (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Table (2017-2030)

12.5.6.2. Market Revenue and Forecast, by End User (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.5.6.4. Market Revenue and Forecast, by Equipment (2017-2030)

Chapter 13. Company Profiles

13.1. Micronit

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. MIMETAS

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3.     

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Nortis Bio

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. TisssUse

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. InSphero

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Elvesys

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Mesobiotech

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. AxoSim

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Emulate Bio

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Tags:

Post a Comment

0 Comments